期刊文献+

CEA-rV对巨噬细胞抗原提呈功能的影响 被引量:2

The Effect of CEA-rV on Antigen-presenting Ability of Macrophage
下载PDF
导出
摘要 目的:探讨 CEA-rV对巨噬细胞抗原提呈功能的影响。方法:采用混合淋巴细胞反应(MLR)检测 Mφ的抗原提呈功能,采用流式细胞仪(FCM)检测Mφ表面分子MHC-Ⅰ(H-2Kb)、MHC-Ⅱ(Ⅰ-Ab)及B7(B7-2)的表达,采用荧光抗体直接染色法检测肿瘤细胞表面H-2Kb、Ⅰ-Ab的表达。结果:CEA-rV接种小鼠腹腔Mφ组(CEA-rVMφ组)T细胞分泌IL-2的水平较W-VV及VS组显著增强(P<0.01),小鼠腹腔Mφ自身表达的Ⅰ-Ab和B7-2分子较低(分别为41.7%,13.7%),接种W-VV后其Ⅰ-Ab及B7-2分子表达改变不明显(分别为44.3%,15.l%),而接种 CEA-rV后其Ⅰ-Ab及 B7-2分子表达明显增强(分别为 87.2%,39.5%)。各组CEA阳性肿瘤细胞表面分子MHC-Ⅰ强表达,却没有 MHC-Ⅱ表达。结论:CEA-rV腹腔接种 Mφ可使 Mφ抗原提呈功能显著增强,Mφ的表面分子MHC-Ⅱ与B7-2表达增强可能是其抗原提呈功能增强的主要原因。提示MHC-Ⅱ与B7-2可能在CEA-rV抗瘤中发挥重要作用。 Objective: To investigate the effect of CEA-rV on antigen-presenting ability of macrophage( Mφ). Methods :In this study, the antigen-presenting ability of Mφ was detected by mix lymphocyte reaction ( MLR) , the expressions of cell surface molecules MHC-Ⅰ(H-2Kb)、MHC-Ⅱ(I-Ab) and B7(B7-2) on mouse Mφ were detected by flow-cytometry (FCM),and the expressions of H-2Kb and I-Ab on CEA positive tumor cell surface were detected by direct fluorescence antibody staining. Results: IL-2 level from T cells incubated with CEA-rV Mφ was significantly increased compared to that of W-VV group or NS group ( P < 0. 01 ). The expressions of I-Ab and B7-2 on mouse Mφ.treated with CEA-rV were significantly increased (87.2% and 39.5 % respectively) compared to that on W-VV treated Mφ(44.3% and 15. 1% respectively) or Hanks treated Mφ(41.7% and 13.7% respectively) ,while there was no significant difference in the expression of H-2K between different groups. Strong MHC-Iexpression, but not MHC-Ⅱ expression on the CEA positive tumor cellswere revealed by routine fluorescence-activated immunohistochemistry analysis,and there was no difference between the CEA-rV treated group.Hanks treated group and W-VV treated group. Conclusion: It could be deduced that CEA-rV enhances the antigen-presenting ability of CEA-rV Mφ which may due to the upregulaion of the expression of I-Ab.B7-2 on CEA-rV Mφ. I-Ab and B7-2 may play important roles in anti-tumor of CEA-rV.
出处 《广州医学院学报》 2002年第1期4-7,共4页 Academic Journal of Guangzhou Medical College
基金 广州市科委基金资助项目(No.JB02-98-5-018-01) 广东省卫生厅资助课题(No.A1998127) 广州医学院资助课题(No.2000-GK-14) 广州医学院博士启动基金资助课题
关键词 癌胚抗原 重组痘苗病毒 巨噬细胞 抗原提呈功能 CEA-RV 肿瘤细胞 carcinoembryonic antigen recombinant vaccinia virus macrophage antigen presentation
  • 相关文献

参考文献13

  • 1赵青,陶莎,杨洁,罗超权.CEA重组痘苗病毒免疫治疗CEA阳性肿瘤机制的研究[J].中国免疫学杂志,2001,17(2):79-81. 被引量:5
  • 2赵青,陶莎,杨洁,尧宏斌,谢金卫,罗超权.接种CEA重组痘苗病毒对小鼠CEA^+肿瘤抑制作用的机制探讨[J].细胞与分子免疫学杂志,2001,17(4):324-327. 被引量:3
  • 3雷虹,曹雪涛,于益芝,朱学军,陈国友,张明徽.腺病毒介导M-CSF和IFN-γ基因联合转染对巨噬细胞抗原提呈功能的影响[J].中国免疫学杂志,1998,14(6):399-402. 被引量:2
  • 4方福德,周吕,丁濂,等.现代医学实验技巧全书,第一版[M].北京医科大学中国协和医科大学联合出版社,1999.
  • 5陈习武,何球藻.抗原递呈细胞在肿瘤免疫中的作用[J].肿瘤,1998,18(4):300-301. 被引量:1
  • 6Tang KC,Hosi J,Grabble S. Epidermal cells presentation of tumor associated anigen for the induction of tolerance[J]. J Immunol,1994,152:3410.
  • 7June CH,Bluestone JA,Nadler LM,et al.The B7 and CD28 receptor famillies[J]. Immunol today,1994,15(7):321.
  • 8Hodge JW,McLaughlin JP,Abrams SI,et al. Admixture of a recombinant vaccinia virus containing the gene for the costimulatory molecule B7 and a recombinant vaccinia virus containing a tumor-associated antigen gene results in enhanced specific T-cell responses and antitumor immunity. [J]. Cancer Res,1995 Aug 15;55(16): 3598-603.
  • 9Lorenz MG,Kantor JA,Schlom J,et al. Anti-tumor immunity elicited by a recombinant vaccinia virus expressing CD70(CD27L)[J]. Hum Gene Ther,1999,10(7):1095.
  • 10Sensi M and Parmiani G. Analysis of TCR usage in human tumors[J]: a new tool for assessing tumor-specific immune responses Immunol Today,1995,16(12):588.

二级参考文献14

共引文献7

同被引文献14

  • 1杨洁,赖晃文,罗超权,杨太成,徐国恒,王晓怀.人癌胚抗原cDNA-重组痘苗病毒接种动物的研究[J].中山大学学报(医学科学版),1997,17(S1):46-48. 被引量:4
  • 2刘晓玲,汪涛,王雯,姜缨,郑伟.SCC-Ag、CEA在肺癌患者血清中的表达及临床意义[J].西安交通大学学报(医学版),2004,25(5):468-469. 被引量:7
  • 3Norton JA. Carcinoembryonic antigen. New application for an old marker. Ann Surg,1991,213(2) :95
  • 4Marshal JL,Gulley JL,Arlen PM, et al. Phase I study of sequential vaccinations with fowlpox-CEA (6D) -TRICOM alone and sequentially with vaccinia-CEA ( 6D )-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinoma. Journal of Clin Oncol,2005,23 (4) :720
  • 5赵青 郭俊明 罗超权.癌胚抗原阳性肿瘤的基因治疗[A].见:罗超权主编.基因诊断与基因治疗研究进展[C].郑州:河南医科大学出版社,2000.254.
  • 6Kantor J. Irvine K, Abram SI, et al. Antitumor activity and immune response induced by a recombinant Carcinoembryonic antigen-vaccinia virus vaccine. J Natl Cancer Inst,1992,84(14) :1 084
  • 7Kantor J,Irvine K,Abram S,et al.Antitumor activity and immune response induced by a recombinant Carcinoembryonic antigen-vaccinia virus vaccine[J].J Natl Cancer Inst,1992,84(14):1084~1089
  • 8Norton JA.Carcinoembryonic antigen.New application for an old marker[J].Ann Surg,1991,213(2):95~97
  • 9Qi YC,Wang XS,Yang B,et al.Preventive and therapeutic effect of CEA recombinant vaccinia virus on CEA positive tumor[J].J Tumor Marker Oncol,2004,19(5):409~413
  • 10Ullenhag GJ,Frodin JE,Jeddi-tehrani M,et al.Durable carcinaoembryonic antigen (CEA)-specific humoral and cellular immune responses in colorectal carcinoma patients vaccinated with recobinant CEA and granulocyte/macrophage colony-stimulating factor[J].Clin Cancer Res,2004,10(10):3273~3281

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部